Wells Fargo initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $68.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/9/2026 | $68.00 | Overweight | Wells Fargo |
| 9/5/2025 | $56.00 | Neutral | Robert W. Baird |
| 7/14/2025 | $58.00 | Mkt Outperform | Citizens JMP |
| 6/16/2025 | Outperform | William Blair | |
| 6/16/2025 | $48.00 | Buy | Truist |
| 6/16/2025 | $48.00 | Buy | Stifel |
| 6/16/2025 | $45.00 | Outperform | Raymond James |
| 6/16/2025 | $41.00 | Overweight | Piper Sandler |
HingeSelect now offers coordinated care covering physical therapy, specialist evaluations, imaging, non-surgical procedures, prehabilitation, surgery and post-operative recovery.Hinge Health, Inc. (NYSE:HNGE) today announced the expansion of HingeSelect to include orthopedic surgery, now delivering care across the entire musculoskeletal (MSK) journey. Members begin with first-line treatment and orthopedic evaluation to determine whether surgery is appropriate. When surgery is needed, Hinge Health supports the journey from pre-op through recovery, connecting members to high-quality surgeons through the HingeSelect network.Surgery accounts for about half of MSK costs1 with an orthopedic surger
Full year 2026 revenue guidance raised to a range of $818 million to $824 million, up $20 million at the midpoint from its prior range and marking 40% year-over-year growth Full year 2026 non-GAAP operating margin of 27% now expected at the midpoint Tomorrow, June 10, Hinge Health, Inc. (NYSE:HNGE) will host its inaugural Investor Day at Movement - the company's annual conference that brings employers, health plans, consultants, providers and clinical experts together to discuss the evolution of healthcare. The Investor Day presentations will begin at 1:00 pm CT and the session will be available via webcast on Hinge Health's investor relations website. During the session, investors w
The study analyzed over 200,000 participants from nearly 1,000 employers over five years, finding $2,941 savings per member annually Hinge Health, Inc. (NYSE:HNGE) today announced the results of the most comprehensive medical claims analysis of its digital musculoskeletal (MSK) solution, demonstrating an average cost savings of $2,941 per member per year using its chronic MSK program and a 3.0x ROI for employers and health plans. With a rigorous methodology independently reviewed by Howden, a global leading benefits consultant, the study dwarfs all prior ROI studies in digital MSK. It analyzed claims data for more than 200,000 commercially-insured adults ages 18-64 across nearly 1,000 e
Wells Fargo initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $68.00
Robert W. Baird initiated coverage of Hinge Health with a rating of Neutral and set a new price target of $56.00
Citizens JMP initiated coverage of Hinge Health with a rating of Mkt Outperform and set a new price target of $58.00
4 - Hinge Health, Inc. (0001673743) (Issuer)
4 - Hinge Health, Inc. (0001673743) (Issuer)
4 - Hinge Health, Inc. (0001673743) (Issuer)
8-K - Hinge Health, Inc. (0001673743) (Filer)
8-K - Hinge Health, Inc. (0001673743) (Filer)
144 - Hinge Health, Inc. (0001673743) (Subject)
Hinge Health, Inc. (NYSE:HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. "Tyler brings decades of deep operating experience," said Daniel Perez, Co-Founder and CEO, Hinge Health. "His track record of scaling public companies with operational rigor and financial discipline will be instrumental as we advance our mission to automate healthcare delivery." As a seasoned executive and board member, Sloat has nearly three decades of operational leadership guid
Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the first quarter ended March 31, 2026. "We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs," said Daniel Perez, Co-Founder and CEO, Hinge Health. "Based on this momentum, we're raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn't build this company to s
Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting wit
Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the fourth quarter and full year 2025 after the U.S. financial markets close on Tuesday, February 10, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, st